MYOG: give or take endpoint results of average 45 meter increased efficiancy in run, results balanced investors sentiment of worth of stock to be 8 million per eeked out new meter advantage over plecebo, pounded into new market cap of this fiesty drug mkaer (just a running appraisal IMHO)..